Novartis Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Novartis Quarterly Results    (NVRT)

Here are the latest quarterly results of Novartis. For more details, see the Novartis financial fact sheet and Novartis share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Novartis Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-18
3
Sep-18
3
Dec-18
3
Mar-19
3
Jun-19
3
Sep-19
3
Dec-19
3
Mar-20
8-Qtr Chart
Click to enlarge
Net Sales Rs m1,3811,0661,3561,1041,0931,1781,175937 
Other income Rs m2233111151341091007379 
Turnover Rs m1,6041,3771,4711,2381,2021,2781,2481,016 
Expenses Rs m1,4161,2421,2219051,1451,2061,085827 
Gross profit Rs m-35-176135199-52-2890110 
Depreciation Rs m7710932313335 
Interest Rs m1500012171719 
Profit before tax Rs m1661282403241324114136 
Tax Rs m66341111295763768 
Profit after tax Rs m100941291958-527768 
Gross profit margin %-2.5-16.510.018.0-4.8-2.47.711.8 
Effective tax rate %39.726.946.439.739.7317.532.150.0 
Net profit margin %7.28.89.517.70.7-4.46.67.2 
Diluted EPS Rs 0.3 0.3 0.4 0.6 0.0 -0.2 0.2 0.2  
Diluted EPS (TTM) Rs 2.4 1.9 1.8 1.5 1.3 0.8 0.7 0.3  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Novartis 3QFY20 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   GSK PHARMA  FDC LTD.  ASTRAZENECA PHARMA  LUPIN  FRESENIUS KABI ONCO.  

Compare NOVARTIS With:   GSK PHARMA  FDC LTD.  ASTRAZENECA PHARMA  LUPIN  FRESENIUS KABI ONCO.  

Compare NOVARTIS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 143 Points Lower; Banking and Finance Stocks Witness Selling(Closing)

Indian share markets witnessed selling pressure throughout the day today, tracking weak global cues as coronavirus cases continue to surge across the world.

Views on news

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (1QFY20); Net Profit Down 92.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NOVARTIS has posted a net profit of Rs 8 m (down 92.1% YoY). Sales on the other hand came in at Rs 1 bn (down 20.8% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1 (Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Two Agri Stocks Are Likely to Outperform Even in this Market (Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

A Warning for Traders: Don't Get Addicted to Hopium (Fast Profits Daily)

Jun 30, 2020

If you are a trader, you must watch out for this dangerous addiction.

Smallcaps Are in a Sweet Spot Again: Are You Buying? (Profit Hunter)

Jul 3, 2020

This is why I believe smallcaps are the place to be in the near future.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Jul 10, 2020 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON NOVARTIS

NOVARTIS - ADCOCK INGRAM COMPARISON

COMPARE NOVARTIS WITH

MARKET STATS